Adam Runkle

Adam Runkle is an experienced regulatory affairs professional currently serving as Associate Director of Regulatory Affairs at Daiichi Sankyo, Inc. since February 2024. Prior to this role, Runkle was the Owner of keV Pharma Consulting, LLC, providing expertise in cGMP compliance and regulatory matters for the radiopharmaceutical industry from March 2014 to March 2024. Runkle held various significant positions including Associate Director of Regulatory Affairs at Kite Pharma and Director of Regulatory Affairs at Tmunity Therapeutics Incorporated. Runkle's comprehensive background includes nearly a decade at the University of Pennsylvania School of Medicine, where responsibilities spanned scientific program management and regulatory compliance within translational science. Runkle's educational qualifications include a Master's degree in Law focusing on Pharmaceutical Regulation and Health Law and a Master's degree in Regulatory Affairs from the University of Pennsylvania, alongside dual Bachelor of Science degrees in Chemistry and Physics from the University of Michigan.